Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. American Society of Breast Surgeons website. Consensus guideline on concordance assessment of image-guided breast biopsies and management of borderline or high-risk lesions. www.breastsurgeons.org/docs/ statements/Consensus-Guideline-on-Concordance-Assessment-of-ImageGuided-Breast-Biopsies.pdf. Accessed April 4, 2023.
2. Lewin AA, Mercado CL (2020) Atypical ductal hyperplasia and lobular neoplasia: update and easing of guidelines. AJR Am J Roentgenol 214(2):265–275. https://doi.org/10.2214/AJR.19.21991
3. Falomo E, Adejumo C, Carson KA, Harvey S, Mullen L, Myers K (2019) Variability in the management recommendations given for high-risk breast lesions detected on image-guided core needle biopsy at U.S. academic institutions. Curr Probl Diagn Radiol 48(5):462–466. https://doi.org/10.1067/j.cpradiol.2018.06.004
4. Krishnamurthy S, Bevers T, Kuerer HM, Smith B, Yang WT (2017) Paradigm shifts in breast care delivery: impact of imaging in a multidisciplinary environment. AJR Am J Roentgenol 208(2):248–255. https://doi.org/10.2214/AJR.16.17130
5. Sokolova A, Lakhani SR (2021) Lobular carcinoma in situ: diagnostic criteria and molecular correlates. Mod Pathol 34(Suppl 1):8–14. https://doi.org/10.1038/s41379-020-00689-3